CR, LLC, formed from the merger of six clinical research organizations, faced the challenge of launching a cohesive new identity in a highly competitive market. With regulatory pressures driving uniformity across the industry, differentiation was critical for success.
Our proprietary diagnostics identified CR, LLC’s strength in adaptive clinical trials, a pioneering approach in the field. Leveraging extensive industry knowledge and competitive analysis, Abu Digital guided the international management team through a transformative rebranding process. This included selecting a new name, defining a clear market position, crafting a compelling value proposition, devising a new tagline, refining messaging, and establishing a distinct visual identity.
Validation of our strategy came through comprehensive market research involving diverse sponsor feedback globally. This ensured alignment with market needs and preferences.
In addition to strategic direction, Forma executed a comprehensive marketing plan encompassing a new website, targeted email campaigns, SEO strategies, PR initiatives, content creation including whitepapers, brochures, direct mail, and impactful sales materials.
The outcome was profound: CR, LLC achieved significant sales growth, ascended to a top-20 ranking among CROs, and successfully positioned itself for a strategic exit. By effectively communicating its unique value and capabilities, CR, LLC secured a competitive edge in the dynamic clinical research landscape.
